DSM-Firmenich AG (AMS:DSFIR)

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Switzerland Revenue	-	-	214.00M
Switzerland Revenue Growth	-	-	4.90%
Netherlands Revenue	-	-	420.00M
Netherlands Revenue Growth	-	-	-0.94%
Rest of EMEA Revenue	-	-	3.94B
Rest of EMEA Revenue Growth	-	-	26.91%
North America Revenue	-	-	2.93B
North America Revenue Growth	-	-	20.99%
Latin America Revenue	-	-	1.89B
Latin America Revenue Growth	-	-	14.16%
China Revenue	-	-	1.10B
China Revenue Growth	-	-	9.93%
Rest of Asia Revenue	-	-	2.32B
Rest of Asia Revenue Growth	-	-	26.83%
Revenue (Total)	13.01B	9.03B	9.05B
Revenue (Total) Growth	44.02%	-0.22%	-14.80%

Revenue

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Perfumery & Beauty (P&B) Revenue	3.95B	3.89B	3.96B
Perfumery & Beauty (P&B) Revenue Growth	1.36%	-1.79%	6.88%
Taste, Texture & Health (TTH) Revenue	3.30B	3.25B	3.25B
Taste, Texture & Health (TTH) Revenue Growth	1.48%	0.18%	6.81%
Health, Nutrition & Care (HNC) Revenue	2.20B	2.08B	2.21B
Health, Nutrition & Care (HNC) Revenue Growth	5.48%	-6.01%	-2.47%
Animal Nutrition & Health (ANH) Revenue	3.54B	3.27B	3.32B
Animal Nutrition & Health (ANH) Revenue Growth	8.26%	-1.65%	3.01%
Corporate Revenue	32.00M	27.00M	52.00M
Corporate Revenue Growth	18.52%	-48.08%	-21.21%
Revenue (Other)	-	-3.49B	-3.75B
Revenue (Total)	13.01B	9.03B	9.05B
Revenue (Total) Growth	44.02%	-0.22%	-14.80%

Adjusted EBITDA

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Perfumery & Beauty (P&B) Adjusted EBITDA	866.00M	844.00M	882.00M
Perfumery & Beauty (P&B) Adjusted EBITDA Growth	2.61%	-4.31%	12.64%
Taste, Texture & Health (TTH) Adjusted EBITDA	645.00M	655.00M	615.00M
Taste, Texture & Health (TTH) Adjusted EBITDA Growth	-1.53%	6.50%	10.61%
Health, Nutrition & Care (HNC) Adjusted EBITDA	390.00M	386.00M	371.00M
Health, Nutrition & Care (HNC) Adjusted EBITDA Growth	1.04%	4.04%	-4.63%
Animal Nutrition & Health (ANH) Adjusted EBITDA	598.00M	492.00M	343.00M
Animal Nutrition & Health (ANH) Adjusted EBITDA Growth	21.55%	43.44%	167.97%
Corporate Adjusted EBITDA	-97.00M	-98.00M	-93.00M
Operating Income (Total)	1.18B	711.00M	547.00M
Operating Income (Total) Growth	65.40%	29.98%	-

Key Performance Indicators

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Perfumery & Beauty (P&B) Organic Growth	2.00%	7.00%
Taste, Texture & Health (TTH) Organic Growth	4.00%	8.00%
Health, Nutrition & Care (HNC) Organic Growth	3.00%	1.00%
Animal Nutrition & Health (ANH) Organic Growth	5.00%	5.00%
Total Organic Growth	3.00%	6.00%

Updated Jun 30, 2025. Data Source: Fiscal.ai.